A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata.

[1]  J. Manson,et al.  Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women. , 1997, Contraception.

[2]  J. Manson,et al.  Variation in the Incidence of Uterine Leiomyoma Among Premenopausal Women by Age and Race , 1997, Obstetrics and gynecology.

[3]  B. Runnebaum,et al.  The Endocrinology of Pregnancy , 1997 .

[4]  P. Lumbiganon,et al.  Protective effect of depot‐medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case‐control study , 1996, British journal of obstetrics and gynaecology.

[5]  Jonathan S. Berek,et al.  Novak's Gynecology , 1996 .

[6]  C. la Vecchia,et al.  Reproductive factors and risk of uterine fibroids. , 1996, Epidemiology.

[7]  A. Samadi,et al.  Risk factors for self-reported uterine fibroids: a case-control study. , 1996, American journal of public health.

[8]  P. Wingo,et al.  Rate of Hospitalization for Gynecologic Disorders Among Reproductive‐Age Women in the United States , 1995, Obstetrics and gynecology.

[9]  R. Barbieri,et al.  Abnormal Gene Expression in Uterine Leiomyomas , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[10]  P. Taylor,et al.  Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  R. Barbieri,et al.  Progesterone: A critical role in the pathogenesis of uterine myomas , 1995, American journal of obstetrics and gynecology.

[12]  J. Manson,et al.  Adolescent body mass index and infertility caused by ovulatory disorder. , 1994, American journal of obstetrics and gynecology.

[13]  H. Peterson,et al.  Hysterectomy in the United States, 1988‐1990 , 1994, Obstetrics and gynecology.

[14]  C. la Vecchia,et al.  Oral contraceptive use and risk of uterine fibroids. , 1992, Obstetrics and gynecology.

[15]  I. Romieu,et al.  DETERMINANTS OF UTERINE FIBROIDS , 1991 .

[16]  R B D'Agostino,et al.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. , 1990, Statistics in medicine.

[17]  F. Greenspan.  Basic and Clinical Endocrinology , 1990 .

[18]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[19]  D. Apter,et al.  Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood , 1989, International journal of cancer.

[20]  E. Negri,et al.  Epidemiologic Characteristics of Women With Uterine Fibroids: A Case‐Control Study , 1988, Obstetrics and gynecology.

[21]  D. Collins,et al.  Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. , 1987, The Journal of clinical endocrinology and metabolism.

[22]  C. la Vecchia,et al.  Risk factors for uterine fibroids. , 1986, British medical journal.

[23]  M. Pike,et al.  Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. , 1986, British medical journal.

[24]  M. Pike,et al.  Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. , 1986, Journal of the National Cancer Institute.

[25]  M. Pike,et al.  Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. , 1985, Journal of the National Cancer Institute.

[26]  B. Macmahon,et al.  Age at menarche, urine estrogens and breast cancer risk , 1982, International journal of cancer.

[27]  V. Beral.  ORAL CONTRACEPTIVES AND HEALTH , 1974 .